Citizens Lifts Benitec Biopharma Inc. (BNTC) Price Target on Topline Results for Oculopharyngeal Muscular Dystrophy Treatment
Benitec Biopharma Inc. (NASDAQ:BNTC) is one of the best breakout stocks to invest in.
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Suvretta Capital Management Aaron Cowen | 11,548,351 | $122,989,938 | 3.14% | |
| 2. | Adage Capital Management Phill Gross And Robert Atchinson | 2,120,672 | $22,585,157 | 0.03% | |
| 3. | RA Capital Management Peter Kolchinsky | 1,850,000 | $19,702,500 | 0.21% | |
| 4. | Nantahala Capital Management Wilmot B. Harkey And Daniel Mack | 1,438,371 | $15,318,651 | +39% | 0.56% |
| 5. | Alyeska Investment Group Anand Parekh | 750,000 | $7,987,500 | 0.02% |
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $13.44 | 11,587 | $155,729.28 | 1,848,156 | 2025-12-29 | Filing | |
| $13.44 | 65,800 | $884,352.00 | 9,700,195 | 2025-12-29 | Filing | |
| $13.10 | 2,516 | $32,959.60 | 1,836,569 | 2025-12-26 | Filing | |
| $13.10 | 14,320 | $187,592.00 | 9,634,395 | 2025-12-26 | Filing | |
| $12.85 | 7,400 | $95,090.00 | 1,834,053 | 2025-12-23 | Filing |
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 2,876,380 | $30,719,738 | 0.01% | |
| 2. | 2,378,159 | $25,327,390 | 0.01% | |
| 3. | 1,185,741 | $12,628,141 | 0% | |
| 4. | 931,556 | $9,921,071 | 0% | |
| 5. | 923,006 | $9,830,014 | 1.23% |